Finance

Lists
532488:BOM
Divi's Laboratories Ltd
₹ 9,119.00
+0.87%
(+79.05) 1D
10-р сарын 16, 15:14:18 (GMT+5:30)  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532488...
Open
₹ 9,013.35
High
₹ 9,247.50
Low
₹ 8,985.00
Mkt. cap
2.42ИН
Avg. vol.
33.69 мян
Volume
17.06 мян
Dividend
0.33%
Quarterly dividend
₹ 7.50
Ex-dividend date
2026 оны 7-р сарын 24
P/E ratio
82.75
52-wk high
₹ 10,000.00
52-wk low
₹ 5,648.00
EPS
₹ 110.20
Shares outstanding
265.47 сая
No. of employees
12 мян
Open
₹ 9,013.35
High
₹ 9,247.50
Low
₹ 8,985.00
Mkt. cap
2.42ИН
Avg. vol.
33.69 мян
Volume
17.06 мян
Dividend
0.33%
Quarterly dividend
₹ 7.50
Ex-dividend date
2026 оны 7-р сарын 24
P/E ratio
82.75
52-wk high
₹ 10,000.00
52-wk low
₹ 5,648.00
EPS
₹ 110.20
Shares outstanding
265.47 сая
No. of employees
12 мян
News stories
From web sources and news partners
Profile
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. Wikipedia
About Divi's Laboratories Ltd
CEOKiran S. Divi
Employees11.6 мян
Founded1990 оны 10-р сарын 12
Headquarters-
SectorHealth care
Last report
2026 оны 8-р сарын 1
Fiscal period
Q1 2027
₹ 33.95 / ₹ 24.68
+37.58%beat
Revenue / Est. (INR)
30.80 тэрбум / 27.61 тэрбум
+11.56%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
27.15 тэрбум
26.04 тэрбум
28.31 тэрбум
30.80 тэрбум
Cost of goods sold
10.73 тэрбум
9.45 тэрбум
13.49 тэрбум
9.86 тэрбум
Cost of revenue
10.73 тэрбум
9.45 тэрбум
13.49 тэрбум
9.86 тэрбум
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.54 тэрбум
3.67 тэрбум
3.99 тэрбум
4.08 тэрбум
Operating expense
8.67 тэрбум
8.87 тэрбум
6.68 тэрбум
9.65 тэрбум
Total operating expenses
19.40 тэрбум
18.32 тэрбум
20.17 тэрбум
19.51 тэрбум
Operating income
7.75 тэрбум
7.72 тэрбум
8.14 тэрбум
11.29 тэрбум
Other non operating income
820.00 сая
690.00 сая
-2.23 тэрбум
640.00 сая
EBT including unusual items
9.12 тэрбум
7.80 тэрбум
9.63 тэрбум
11.80 тэрбум
EBT excluding unusual items
9.12 тэрбум
8.54 тэрбум
9.59 тэрбум
11.80 тэрбум
Income tax expense
2.23 тэрбум
1.97 тэрбум
2.12 тэрбум
2.78 тэрбум
Effective tax rate
24.45%
25.26%
22.01%
23.56%
Other operating expenses
4.00 тэрбум
4.02 тэрбум
1.49 тэрбум
4.24 тэрбум
Net income
6.89 тэрбум
5.83 тэрбум
7.51 тэрбум
9.02 тэрбум
Net profit margin
25.38%
22.39%
26.53%
29.29%
Earnings per share
25.97
24.07
28.31
33.95
Interest and investment income
-
-
2.84 тэрбум
-
Interest expense
-80.00 сая
-60.00 сая
-60.00 сая
-60.00 сая
Net interest expenses
-80.00 сая
-60.00 сая
2.78 тэрбум
-60.00 сая
Depreciation and amortization charges
1.13 тэрбум
1.18 тэрбум
1.20 тэрбум
1.33 тэрбум
EBITDA
8.88 тэрбум
8.72 тэрбум
9.29 тэрбум
12.44 тэрбум
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс